Evidence map›Paper›PMID 40885461›Full record

Trial reportJournal of vascular surgery2026

Characteristics of multidisciplinary limb preservation teams and their impact on outcomes in the BEST-CLI trial.

Douglas W Jones, Alik Farber, David G Armstrong, Ezana Azene, Audra Duncan, Thomas M Todoran, Gheorghe Doros, Michael B Strong, Kenneth Rosenfield, Michael S Conte and 1 more

Abstract readMulticenter StudyComparative StudyRandomized Controlled Trial
In one paragraph

Trial report in Journal of vascular surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Douglas W JonesDivision of Vascular and Endovascular Surgery, University of Massachusetts Medical Center, University of Massachusetts Chan Medical School, Worcester, MA. Electronic address: douglas.jones@umassmemorial.org.
Alik FarberDepartment of Surgery, Boston University Chobanian & Avedisian School of Medicine, Boston Medical Center, Boston, MA.
David G ArmstrongSouthwestern Academic Limb Salvage Alliance (SALSA), Department of Surgery, Keck Medical Center of USC, Los Angeles, CA.
Ezana AzeneDepartment of Interventional Radiology, Gundersen Health System, La Crosse, WI.
Audra DuncanDivision of Vascular Surgery, London Health Sciences Center, University of Western Ontario, London, Ontario, Canada.
Thomas M TodoranDivision of Cardiology, Department of Medicine, Medical University of South Carolina, Charleston, SC.
Gheorghe DorosBoston University School of Public Health, Department of Biostatistics, Boston, MA.
Michael B StrongDivision of Vascular and Endovascular Surgery, Brigham and Women's Hospital, Boston, MA.
Kenneth RosenfieldSection of Vascular Medicine and Intervention, Massachusetts General Hospital, Boston, MA.
Michael S ConteDivision of Vascular and Endovascular Surgery, University of California, San Francisco, San Francisco, CA.
Matthew T MenardDivision of Vascular and Endovascular Surgery, Brigham and Women's Hospital, Boston, MA.

Funding

BEST-CLI Trial-DCCU01HL107407 · NHLBI · NEW ENGLAND RESEARCH INSTITUTES, INC. · PI ASSMANN, SUSAN FERA, CZIRAKY, MARK J. · 2013 to 2019
$20.0M
BEST-CLI Trial-CCC-LeadU01HL107352 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI FARBER, ALIK, MENARD, MATTHEW THOMAS · 2013 to 2018
$6.1M
BEST-CLI Trial - Cost-Effectiveness of Treatments for Critical Limb IschemiaU01HL115662 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI CHOUDHRY, NITEESH K · 2013 to 2018
$1.2M
NHLBI NIH HHS U01 HL107352NHLBI NIH HHS U01 HL107407NHLBI NIH HHS U01 HL115662
6 · The paper itself

Abstract

objectiveMultidisciplinary care of chronic limb-threatening ischemia (CLTI) through specialized CLTI teams has been associated with improved outcomes, including decreased major amputations. Our goal was to characterize CLTI teams and examine their association with outcomes in the Best Endovascular vs Best Surgical Therapy in Patients with CLTI (BEST-CLI) trial.

methodsResponses from a previously described post-trial electronic survey were used to describe CLTI care providers and characterize centers based on the presence of a "formally defined team dedicated to the care of patients with CLTI." Patient-level data were analyzed to determine the association of CLTI teams with outcomes. Primary outcomes were: (1) major (above-ankle) amputation and (2) major adverse limb events (MALE) or death from any cause. A secondary outcome was the high-low amputation ratio (ratio of major amputations to minor amputations). Cox multivariable models were used to control for patient demographics, limb stage, and revascularization type.

resultsThe overall survey response rate was 20.2% with at least one response from 75% of enrolling sites. Among survey respondents, specialties identified most frequently as being among those primarily responsible for CLTI care at centers with CLTI teams were revascularization (vascular surgery, interventional cardiology, or interventional radiology, 92%), podiatry (32%), and wound care (22%). Compared with centers without CLTI teams, podiatrists at CLTI team centers were more likely to have a primary role (32% vs 11%) and less likely to be unavailable (4% vs 22%) (P < .001). Similarly, at centers with CLTI teams, wound care specialists were more likely to have a primary role (22% vs 8%) and less likely to be unavailable (4% vs 11%) (P = .02). Effectiveness of teamwork among CLTI providers was described as "highly effective" in 71% of respondents with a CLTI team vs 29% without a team (P < .001). In the BEST-CLI trial, 110 centers (73%) could be classified based on the availability of a CLTI team (31% team vs 69% no team), representing 83% of all enrolled patients (n = 1520). Patients treated at centers with a CLTI team had similar rates of unadjusted 1-year above-ankle amputation (7.9% team [95% confidence interval (CI), 5.7%-10.7%] vs 12.1% no team [95% CI, 10.1%-14.4%]; P = .07) and MALE or death (29% team [95% CI, 25.1%-33.3%] vs 33% no team [95% CI, 30.1%-36.2%]; P = .07). On multivariable analysis, the presence of a CLTI team was found to be independently associated with decreased major amputation (hazard ratio, 0.60 [95% CI, 0.42-0.86]; P = .005) but no significant difference in MALE or death (hazard ratio, 0.89 [95% CI, 0.74-1.06]; P = .2). The high-low amputation ratio was lower at centers with CLTI teams (0.20 [95% CI, 0.14-0.28]) compared with centers with no team (0.31 [95% CI, 0.25-0.38]) (P = .03).

conclusionsIn the BEST-CLI trial, formally defined CLTI teams were associated with a decreased risk of major amputation. This may be partially attributable to more effective communication and closer involvement between vascular specialists, podiatrists, and wound care providers.

Indexed as

Chronic Limb-Threatening IschemiaEndovascular ProceduresIschemiaLimb SalvagePatient Care TeamPeripheral Arterial DiseaseVascular Surgical ProceduresAgedAmputation, SurgicalFemaleHealth Care SurveysHumansMaleMiddle AgedRisk FactorsTime FactorsAmputationEndovascularLimb preservationLower extremity bypassMultidisciplinary team

Identifiers

PMID40885461
PMCPMC12416768

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.